Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SCN4A | P35499 | 1/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1153708 | 1.00 | KDM4E (0.55) | KDM4ELMNAMAPK1CYP2D6CYP2C19 | |
| SCHEMBL11161210 | 1.00 | KDM4E (0.55) | KDM4ELMNAMAPK1CYP2D6CYP2C19 | |
| SCHEMBL11682981 | 0.85 | KDM4E (0.53) | KDM4ELMNAMAPK1CYP2D6LAP3 | |
| SCHEMBL295381 | 0.85 | KDM4E (0.53) | KDM4ELMNAMAPK1CYP2D6LAP3 | |
| SCHEMBL13907299 | 0.83 | SLC6A2 (0.42) | KDM4ELMNAMAPK1CYP2D6CYP2C19 | |
| SCHEMBL295990 | 0.83 | HTT (0.41) | HTTALDH1A1GAAMEN1KMT2A | |
| SCHEMBL1153829 | 0.80 | LNPEP (0.42) | HTTALDH1A1GAAMEN1KMT2A | |
| SCHEMBL1153831 | 0.80 | LNPEP (0.42) | HTTALDH1A1GAAMEN1KMT2A | |
| SCHEMBL7681343 | 0.80 | KDM4E (0.60) | KDM4ELMNAMAPK1CYP2D6LAP3 | |
| SCHEMBL7108436 | 0.80 | KDM4E (0.60) | KDM4ELMNAMAPK1CYP2D6LAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1683783-B1 | Chiral copper complex and production processes thereof and using the same | SUMITOMO CHEMICAL CO (JP) | 2012-03-14 | — | — | EP | disclosed |
| EP-1683782-B1 | Chiral copper complex and production processes thereof and using the same | SUMITOMO CHEMICAL CO (JP) | 2012-03-14 | — | — | EP | disclosed |
| US-7943799-B2 | Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-17 | — | — | US | disclosed |
| US-20110046415-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENEBISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-02-24 | — | — | US | disclosed |
| US-7842839-B2 | Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-30 | — | — | US | disclosed |
| US-7612236-B2 | Method for producing optically active bisamidoalcohol compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-03 | — | — | US | disclosed |
| EP-1120402-B1 | Chiral copper complex and production processes thereof and using the same | SUMITOMO CHEMICAL CO (JP) | 2008-06-25 | — | — | EP | disclosed |
| US-20070112201-A1 | Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-17 | — | — | US | disclosed |
| US-20070100163-A1 | Reacting an optically active aminoalcohol compound with a diester compound in the presence of a lithium compound wherein the lithium compound is selected from lithium hydroxide, a lithium alkoxide and a lithium halide; product can be efficiently and inexpensively produced | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-05-03 | — | — | US | disclosed |
| EP-1698616-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE BISAMIDO ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2006-09-06 | — | — | EP | disclosed |
| EP-0022608-B1 | PROCESS FOR THE PREPARATION OF CYCLOPROPANE CARBOXYLIC ACID ESTERS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-07-06 | — | — | EP | disclosed |
| US-4383112-A | SHIFF BASES; CATALYSTS FOR CYCLOPROPANATION OF OLEFINS BY DIAZOACETATES | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1983-05-10 | — | — | US | disclosed |
| US-4344894-A | TRANSITION METAL COMPLEX OF SCHIFF BASES AS CATALYSTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-08-17 | — | — | US | disclosed |
| US-4343935-A | CATALYSTS FOR CYCLOPROPANIZATION OF OLEFINS BY DIAZOACETATES | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-08-10 | — | — | US | disclosed |
| US-4288387-A | REACTION OF A HALOGENOPENTENE OR HEXENE WITH A DIAZOACETIC ESTER IN THE PRESENCE OF CATALYST WHICH IS METALLIC COPPER, A COPPER SALT, A RHODIUM SALT, OR A TRANSITION METAL COMPLEX OF A CHIRAL SCHIFF BASE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-09-08 | — | — | US | disclosed |
| EP-0024796-A1 | Chiral amino-alcohol complexes and process for their preparation | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-03-11 | — | — | EP | disclosed |
| EP-0023075-A1 | Process for the preparation of cyclopropane carboxylic acid esters | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-01-28 | — | — | EP | disclosed |
| EP-0022608-A1 | Process for the preparation of cyclopropane carboxylic acid esters | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-01-21 | — | — | EP | disclosed |
| US-4029690-A | WITH 2,5-DIMETHYL-2,4-HEXADIENE AND AN ALKYL DIAZOACETATE WITH A COPPER COMPLEX CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-14 | — | — | US | disclosed |
| US-4029683-A | WITH A SCHIFF BASE, CHRYSANTHEMATE SYNTHESIS CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112201-A1 | Method for producing optically active cycloalkylidenebisoxazoline compound and intermediate thereof | CYP3A7, GRK7, CYP2A7 | KDM4E 3354/4885LMNA 1389/4885MAPK1 2947/4885 |
| US-20110046415-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE CYCLOALKYLIDENEBISOXAZOLINE COMPOUND AND INTERMEDIATE THEREOF | CYP3A7, GRK7, CYP2A7 | KDM4E 3354/4885LMNA 1389/4885MAPK1 2947/4885 |
| US-20070100163-A1 | Reacting an optically active aminoalcohol compound with a diester compound in the presence of a lithium compound wherein the lithium compound is selected from lithium hydroxide, a lithium alkoxide and a lithium halide; product can be efficiently and inexpensively produced | CCNL2, ARL1, ACSL3 | KDM4E 2464/4885LMNA 193/4885MAPK1 1770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.